Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brain Perfusion in Rhythm vs Rate Control for Persistent AF
NCT02633774Unknown
- Sponsor
- Yonsei University
- Start
- Nov 2015
- Primary completion
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of propafenone in Atrial fibrillation (AFib) (2 arms), sponsored by Yonsei University. Primary endpoints: Korean version of Montreal Cognitive Assessment at 12 months and Brain perfusion Computed Tomography at 12 months. Status: unknown.
02
Drugs
propafenone
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT02633774.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02633774.